Novel L284R MAPT Mutation in a Family with an Autosomal Dominant Progressive Supranuclear Palsy Syndrome

Background: MAPT mutations are associated with disorders within the frontotemporal lobar degeneration spectrum. The usual presenting syndrome is behavioural variant frontotemporal dementia, although some patients present with parkinsonism. In a number of these cases the dominant clinical features have been consistent with a progressive supranuclear palsy (PSP) syndrome. Objective: To describe a family with an autosomal dominant PSP syndrome with a novel L284R mutation in the MAPT gene. Methods: A retrospective case review and genetic analysis of the MAPT gene. A literature review of PSP syndromes associated with mutations in the MAPT gene. Results: Multiple members of family DRC292 across different generations had a PSP syndrome with 1 member of the family being found to have a novel L284R mutation in the MAPT gene. Behavioural features were also prominent in most cases. A PSP syndrome is only a rare finding associated with MAPT mutations and many of these cases have atypical clinical features. Conclusion: Although rare, MAPT mutations should be considered when there is an autosomal dominant family history of a PSP syndrome, particularly of young onset and with prominent behavioural features.

[1]  Nick C Fox,et al.  The heritability and genetics of frontotemporal lobar degeneration , 2009, Neurology.

[2]  M. Breteler,et al.  Familial aggregation of parkinsonism in progressive supranuclear palsy , 2009, Neurology.

[3]  D. Kareken,et al.  The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family , 2007, Brain : a journal of neurology.

[4]  Dennis W Dickson,et al.  Progressive Supranuclear Palsy: Pathology and Genetics , 2007, Brain pathology.

[5]  M. Spillantini,et al.  Hereditary Frontotemporal Dementia Caused by Tau Gene Mutations , 2007, Brain pathology.

[6]  J. Hoenicka,et al.  A New Mutation of the τ Gene, G303V, in Early-Onset Familial Progressive Supranuclear Palsy , 2005 .

[7]  G. Schellenberg,et al.  Regulation of tau isoform expression and dementia. , 2005, Biochimica et biophysica acta.

[8]  A. Albanese,et al.  Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene , 2004, Annals of neurology.

[9]  N. Quinn,et al.  Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP , 2003, Neurology.

[10]  John Q Trojanowski,et al.  An R5L τ mutation in a subject with a progressive supranuclear palsy phenotype , 2002, Annals of neurology.

[11]  O. Rascol,et al.  Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family. , 2002, Archives of neurology.

[12]  D W Dickson,et al.  Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation. , 2001, Brain : a journal of neurology.

[13]  G. Schellenberg,et al.  Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. , 2001, Archives of neurology.

[14]  E. Tolosa,et al.  Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene , 2001, Annals of neurology.

[15]  P. Schofield,et al.  Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene , 2000 .

[16]  Olivier Rascol,et al.  A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy , 1999, Acta Neuropathologica.

[17]  G. Schellenberg,et al.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[20]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[21]  J. Hoenicka,et al.  A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy. , 2005, Archives of neurology.

[22]  P. Schofield,et al.  Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. , 2000, Brain : a journal of neurology.